EBITDA fell 23.5% and interim dividend cut to zero; FY24 guide ~$50m

The interim dividend was set at zero, against 12.0 cents in HY23, and the board issued FY24 Operating EBITDA guidance of around $50m, well below the $61.2m delivered in FY23.

Operating cash outflow was $6.8m versus $35.0m a year earlier, helped by trade debtors falling 8.6% to $294.2m. Because operating cash flow is being read alongside EBITDA here, note that the OCF/EBITDA ratio for both periods is denominator-distorted and basis-mismatched, so this change should not be characterised as a normal improvement in cash conversion or quality. Gross borrowings still rose to $110.2m from $98.0m, taking net debt/EBITDA to 2.6x from 2.0x. ROE roughly halved, to 14.3% from 24.1%.

PBT fell 40.7% and NPAT fell 40.1%, a gap of just -0.6 percentage points, with the effective tax rate barely changing (27.3% vs 28.4%). The cleaner read is that operating profit dropped 35.5% to $22.2m, so the NPAT decline reflects genuine trading weakness rather than a one-off below-the-line item. Both segments contributed: Retail & Water result fell to $40.0m from $48.9m, and Agency result fell to $1.4m from $3.6m on broadly flat share of revenue.

Dividend suspension signals balance-sheet priority. A 12.0 cent prior interim has gone to zero despite the company still generating $12.7m of NPAT. Combined with gross borrowings up $12.2m and net debt/EBITDA climbing to 2.6x, the read is that the board is preserving liquidity ahead of a softer FY24, not signalling a step-change in payout policy. This matters because PGW historically distributed a large share of earnings (prior NPAT payout 42.9%), so the cut is a behavioural change.

Guidance implies almost all of the FY24 damage is now visible. FY24 EBITDA of ~$50m versus HY24 EBITDA of $36.6m leaves an implied H2 of ~$13.4m, almost identical to the implied FY23 H2 of $13.4m. Management is therefore telling investors the H1 shortfall is structural for the year, not a phasing effect to be recovered.

On that pattern HY24's $36.6m extrapolates to a full-year figure well above $50m, which the company is explicitly disowning. The takeaway is that the H2 EBITDA contribution is not expected to improve materially on the soft H2 FY23.

No revenue or margin target has been provided, only the EBITDA anchor. That leaves limited basis for judging the path back to FY22 or FY23 earnings levels; the release supports a flat-to-soft H2 view but not a recovery thesis.

Separately, debtor days eased to 95 from 100 on lower revenue, a real working-capital effect, but on a source-backed basis it does not by itself offset the underlying earnings deterioration: free cash flow pre-lease was -$13.7m versus +$8.3m a year ago, and FCF/NPAT was -107.8%.

So the durable read is that trading earnings stepped down, working capital partly cushioned the cash impact, and the balance sheet absorbed the rest via higher gross borrowings and a suspended dividend. Capex was modest at $6.9m (1.2% of revenue), so the cash strain is operating, not investment-driven. Given the denominator distortion noted above, this section deliberately avoids citing the OCF/EBITDA percentage values as trend evidence.

This briefing cannot assess underlying segment volume or pricing trends, peer comparatives, or the durability of the working-capital improvement beyond seasonal effects. It also cannot rely on the reported OCF/EBITDA ratio, which is flagged as denominator-distorted and not analytically comparable across periods.